EXERKINE

Exerkine Corporation is a biotechnology company developing novel therapies for the treatment of genetic and aging-associated diseases. Exerkine's focus is on developing and commercializing therapies that can materially improve the lives of patients... In addition to our exosome-based technology, we have developed a number of therapies based on Exerkines™ that have the potential to treat aging-associated diseases, such as obesity, type 2 diabetes, cardiovascular diseases, and neurodegenerative diseases.

Also known as: Exerkine Corporation, Exerkine Inc.